Mouse rivalry tightens

Several additional genes, a few lawsuits and a missed IPO later, Cell Genesys Inc.'s Abgenix Inc. subsidiary appears to have caught up with GenPharm International in their race to develop a transgenic mouse that produces high affinity human antibodies to any antigen.

The picture was different in 1994, when the rivals published separate papers demonstrating that their mice produced human monoclonal antibodies to several

Read the full 632 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE